A regulatory role for CD37 in T cell proliferation
- PMID: 14978098
- DOI: 10.4049/jimmunol.172.5.2953
A regulatory role for CD37 in T cell proliferation
Abstract
CD37 is a leukocyte-specific protein belonging to the tetraspanin superfamily. Previously thought to be predominantly a B cell molecule, CD37 is shown in this study to regulate T cell proliferation. CD37-deficient (CD37(-/-)) T cells were notably hyperproliferative in MLR, in response to Con A, or CD3-TCR engagement particularly in the absence of CD28 costimulation. Hyperproliferation was not due to differences in memory to naive T cell ratios in CD37(-/-) mice, apoptosis, or TCR down-modulation. Division cycle analyses revealed CD37(-/-) T cells to enter first division earlier than wild-type T cells. Importantly, proliferation of CD37(-/-) T cells was preceded by enhanced early IL-2 production. We hypothesized CD37 to be involved in TCR signaling and this was supported by the observation that CD4/CD8-associated p56(Lck) kinase activity was increased in CD37(-/-) T cells. Remarkably, CD37 cross-linking on human T cells transduced signals that led to complete inhibition of CD3-induced proliferation. In the presence of CD28 costimulation, CD37 engagement still significantly reduced proliferation. Taken together, these results demonstrate a regulatory role for CD37 in T cell proliferation by influencing early events of TCR signaling.
Similar articles
-
Lck is required for activation-induced T cell death after TCR ligation with partial agonists.J Immunol. 2004 Feb 1;172(3):1437-43. doi: 10.4049/jimmunol.172.3.1437. J Immunol. 2004. PMID: 14734719
-
Activated p56lck directs maturation of both CD4 and CD8 single-positive thymocytes.J Immunol. 2001 Feb 15;166(4):2209-17. doi: 10.4049/jimmunol.166.4.2209. J Immunol. 2001. PMID: 11160274
-
Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.J Immunol. 1999 Jan 15;162(2):799-806. J Immunol. 1999. PMID: 9916701
-
From naive to memory T cells.Immunol Rev. 1996 Apr;150:143-67. doi: 10.1111/j.1600-065x.1996.tb00700.x. Immunol Rev. 1996. PMID: 8782706 Review. No abstract available.
-
SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells.Immunol Rev. 2009 Nov;232(1):319-33. doi: 10.1111/j.1600-065X.2009.00839.x. Immunol Rev. 2009. PMID: 19909373 Free PMC article. Review.
Cited by
-
Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.Mol Ther Methods Clin Dev. 2021 Oct 5;23:359-369. doi: 10.1016/j.omtm.2021.09.019. eCollection 2021 Dec 10. Mol Ther Methods Clin Dev. 2021. PMID: 34729382 Free PMC article.
-
CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.Int J Mol Sci. 2020 Dec 15;21(24):9531. doi: 10.3390/ijms21249531. Int J Mol Sci. 2020. PMID: 33333768 Free PMC article. Review.
-
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies.Blood. 2011 Oct 13;118(15):4159-68. doi: 10.1182/blood-2011-04-351932. Epub 2011 Jul 27. Blood. 2011. PMID: 21795744 Free PMC article.
-
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study.Invest New Drugs. 2018 Oct;36(5):869-876. doi: 10.1007/s10637-018-0570-4. Epub 2018 Feb 17. Invest New Drugs. 2018. PMID: 29453628 Free PMC article. Clinical Trial.
-
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.Blood. 2016 Dec 29;128(26):3083-3100. doi: 10.1182/blood-2016-05-715094. Epub 2016 Oct 19. Blood. 2016. PMID: 27760757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous